Adenovirus E4ORF1 activates isoform-specific phosphatidylinositol 3-kinase signaling in human endothelial cells

The human adenovirus serotype 5 E4ORF1 (Ad5E4ORF1) protein promotes primary endothelial cell survival and angiocrine functions by hijacking the cellular phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. However, the mechanism by which E4ORF1 activates PI3K in vascular cells remains largely unknown. Here, we show that Ad5E4ORF1 recruits multiple host scaffold proteins, including DLG1, which facilitates AKT activation in response to both Ad5E4ORF1 and endogenous receptor agonists in human endothelial cells. Furthermore, Ad5E4ORF1 specifically engages the human PI3K isoform p110α-p85β through multidomain interactions exclusively with p110α. Notably, E4ORF1 proteins from different adenoviral serotypes differentially interact with p110α, resulting in varying levels of AKT activation in endothelial cells. We propose that E4ORF1 specifically recognizes and allosterically activates p110α-p85β via direct multisite contacts with p110α.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-11-17
DOI
https://doi.org/10.1016/j.jbc.2025.110947
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adenovirus E4ORF1 activates isoform-specific phosphatidylinositol 3-kinase signaling in human endothelial cells

TuKiet T. Lam, Raphaël Lis, Jean E. Kanyo, Jae-Hung Shieh et al.
Journal of Biological Chemistry
Virus-based gene therapy research
article

Adenovirus E4ORF1 activates isoform-specific phosphatidylinositol 3-kinase signaling in human endothelial cells

TuKiet T. Lam, Raphaël Lis, Jean E. Kanyo, Jae-Hung Shieh, Dominick Romano, Jie Geng, Sina Y. Rabbany, Fuqiang Geng, Shahin Rafii, Ying Liu, Lin Yang, Mariko Kobayashi, Kevin Chen, Jesús M. Gómez-Salinero, Arash Rafii, Michael Ginsberg
article en

Abstract

The human adenovirus serotype 5 E4ORF1 (Ad5E4ORF1) protein promotes primary endothelial cell survival and angiocrine functions by hijacking the cellular phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. However, the mechanism by which E4ORF1 activates PI3K in vascular cells remains largely unknown. Here, we show that Ad5E4ORF1 recruits multiple host scaffold proteins, including DLG1, which facilitates AKT activation in response to both Ad5E4ORF1 and endogenous receptor agonists in human endothelial cells. Furthermore, Ad5E4ORF1 specifically engages the human PI3K isoform p110α-p85β through multidomain interactions exclusively with p110α. Notably, E4ORF1 proteins from different adenoviral serotypes differentially interact with p110α, resulting in varying levels of AKT activation in endothelial cells. We propose that E4ORF1 specifically recognizes and allosterically activates p110α-p85β via direct multisite contacts with p110α.

Journal of Biological ChemistryVol. 302(1)
Hofstra University (US), California Institute for Regenerative Medicine (US), Cornell University (US), W. M. Keck Foundation (US), Yale University (US), Angiocrine Bioscience (United States) (US), Regenerative Medicine Institute (MX), Weill Cornell Medical College in Qatar (QA)
Openalex Percentile: Top 63%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.